Email this article METABOLIC SYNDROME IN CANCER PATIENTS AFTER CHEMOTHERAPY IN THAI NGUYEN NATIONAL HOSPITAL
About this article
Received: 19/02/20 Revised: 11/06/20 Published: 22/06/20Authors
1. Nguyen Thi Hoa
, TNU - University of Medicine and Pharmacy2. Tran Thi Kim Phuong, TNU - University of Medicine and Pharmacy
Abstract
Study to determining the levels of plasma some biochemistry test related to metabolic syndrome in levels in cancer patients before and after chemotherapy. By a longitudinal study method of 266 cancer patients were treated at least 6 cycles of chemotherapy in Oncology department in Thai Nguyen National hospital. The results show that after the 6th cycle, some characteristics of metabolic syndrome include weight, BMI and blood pressure were higher than before chemotherapy (p>0.05). Fasting levels of plasma glucose, total cholesterol, triglycerides, LDL-C were significantly higher than before chemotherapy, fasting levels of plasma HDL-C was significantly lower than before chemotherapy. The hypertension was 31.9%, the prediabete was 21.4%, the diabete was 7.4%, the at least one component of lipid profile disorder was 64.3%, the metabolic syndrome was 22.9%. After chemotherapy statistically significantly increases some component of metabolic syndrome. The metabolic syndrome was 22.9%.
Keywords
Full Text:
PDF (Tiếng Việt)References
[1]. S. Casco, and E. Soto-Vega, "Development of Metabolic Syndrome Associated to Cancer Therapy: Review," Horm Cancer, vol. 7, no. 5-6, pp. 289-295, 2016.
[2]. C. M. Dieli-Conwright, L. Wong, and S. Waliany, "An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy," Cancer, vol. 122, no. 17, pp. 2646-2653, 2016.
[3]. F. Liang, S. Zhang, and H. Xue, "Risk of second primary cancers in cancer patients treated with cisplatin: a systematic review and meta-analysis of randomized studies," BMC Cancer, vol. 17, no. 1, p. 871, 2017.
[4]. Ministry of Health, Guidelines for the diagnosis and treatment of cancer at Decision 3338/QĐ-BYT 9th, September, 2013.
[5]. C. Oudin, M. C. Simeoni, and N. Sirvent, "Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia," Blood, vol. 117, no. 17, pp. 4442-4448, 2011.
[6]. E. C. De Haas, R. Altena, and H. M. Boezen, "Early development of the metabolic syndrome after chemotherapy for testicular cancer," Ann Oncol, vol. 24, no. 3, pp. 749-755, 2013.
[7]. H. W. Chueh, and J. H. Yoo, "Metabolic syndrome induced by anticancer treatment in childhood cancer survivorsm," Ann Pediatr Endocrinol Metab, vol. 22, no. 2, pp. 82-89, 2017.
[8]. N. L. Westerink, J. Nuver, and J. D. Lefrandt, "Cancer treatment induced metabolic syndrome: Improving outcome with lifestyle," Crit Rev Oncol Hematol, vol. 108, pp. 128-136, 2016.Refbacks
- There are currently no refbacks.